Eli Lilly takes weight-loss pill battle global with first Foundayo approval in Europe

Read full story on CNBC Markets
Share
Eli Lilly takes weight-loss pill battle global with first Foundayo approval in Europe
AI disclosure

Summary

Lilly's Foundayo wins U.K. approval, taking its weight-loss pill battle with Novo Nordisk's Wegovy beyond the U.S. market.

Original reporting

Open original source

Related coverage

Read full article on CNBC Markets

Get the AFBytes Brief

Major stories, AI-assisted analysis, and what to watch next. Free, monthly, unsubscribe anytime.